AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 191 min read$SHC

Petras Michael B. Jr. sold $15.7M of SHC (indirect holdings)

Petras Michael B. Jr. (Executive Chairman) sold 850,000 indirectly-held shares of Sotera Health Co (SHC) at $18.50 ($15.73M total) on 2026-08-17.

Original reporting
SEC EDGAR · Petras Michael B. Jr.
Published Aug 19, 2026, 8:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$SHC
Bearish
medium confidence
Mentioned
$SHC
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SHCBearishLow
01

Why it matters

The sale reduces insider ownership, which may be interpreted as a bearish sign.

02

Market read

Direct impact on SHC stock; limited broader market effect.

03

What to watch

No accompanying earnings or guidance change; market may discount the sell.

Relevance 7/10Novelty 6/10Timing: post-market 2026-08-17

Background

Form 4 filing discloses insider transactions to the SEC.

Company-level read

Ticker impact

$SHCBearishMedium confidence
Context

Executive Chairman sold 850,000 shares for $15.7M, reducing his stake to 3.97M shares.

Expected impact

Potential modest decline in SHC price over the next few days.

Evidence & confidence

Significant insider sell by a top executive often signals lack of confidence, but no other catalyst is present.

Market effects

Sector

Minimal impact on healthcare services sector.

Regional

US market only.

Global

Low

Counterpoint

What could challenge this read

Insider sell could be routine diversification, not a negative signal.

Key entities

  • Executive Chairman
    Petras Michael B. Jr.

    Reported insider sale of SHC shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SHC insider trading history →

Related articles

AUG 19
$AVTRMed

Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

Avantor (AVTR) reported Q2 revenue of $1.69B, flat YoY, beating estimates by 4.9%, with stock up 8.2%. Bruker (BRKR) reported $838.5M revenue, up 5.2% YoY, missing estimates by 1.9%, with stock down 11.6%. Sotera Health (SHC) reported $321.4M revenue, up 9.2% YoY, beating estimates by 3.8%, with stock up 2.9%. Bio-Techne (TECH) reported $321.2M revenue, up 1.3% YoY, beating estimates by 2%, with stock flat.

yahoo.com3 min
AUG 6
$SHCHighAI 9/10

Sotera Health Company: Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

Sotera Health (Nasdaq: SHC) reported Q2 2026 net revenues up 9.2% (8.0% constant currency) to $?, with net income $54 million ($0.19/share) versus $8 million ($0.03) a year earlier. Adjusted EPS was $0.26, and Adjusted EBITDA margin rose to 51.6%. The company raised FY 2026 outlook for net revenues to $1.236-$1.254B and Adjusted EBITDA to $634-$643M.

finanznachrichten.de6 min
AUG 6
$SHCHigh

Sotera Health Co (SHC): Results of Operations and Financial Condition

Sotera Health Co (SHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook • Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis (1) compared to Q2 2025 • Q2 2026 net income of $54 million or $0.19 per diluted share, comp

SEC EDGAR 8-K4 min